Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
M
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Meghan D. Jones's research has explored several areas within health sciences. Her work includes a retrospective review of musculoskeletal care within a military health system and an examination of the duration of lymphopenia after CAR-T cell therapy and its association with non-melanoma skin cancers and survival rates. Jones also investigated early administration of bispecific antibodies following CAR-T infusion for specific lymphoma types. Her earlier research involved the synthesis and in vitro evaluation of disquaramide compounds as potential anti-leishmanial drugs. Jones has collaborated with researchers from the University of Arkansas for Medical Sciences and the University of Central Arkansas.
Metrics
- Publications: 3
Selected Publications
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
-
Comparing Administration of Nutrition Support With Prescribed Dose (2011)
Collaboration Network
Top Collaborators
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Assyl Arykbayeva
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gabriel Gifford
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Eva R. Palmer
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alex Rogers
University of Central Arkansas (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Emily N. H. Tran
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Lucy Fry
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alexx Weaver
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Anne K. Bowlin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Michael R. Eledge
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Karl W. Boehme
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gregory R. Naumiec
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Tiffany Weinkopff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Similar Researchers
Based on overlapping research topics
Cesar Gentille
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Lymphoma Diagnosis and Treatment
Microbial infections and disease research
Michael R. Bishop
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Lymphoma Diagnosis and Treatment
Retrospective Studies
Chenghui Li
University of Arkansas for Medical Sciences
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Retrospective Studies
Ruud Dings
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Microbial infections and disease research
Immune Response and Inflammation
Cade Richesin
University of Arkansas at Fayetteville
CAR-T cell therapy research
Lymphoma Diagnosis and Treatment
Immune Response and Inflammation
Sean Plummer
University of Arkansas at Fayetteville
Lymphoma Diagnosis and Treatment
Retrospective Studies
Immune Response and Inflammation